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Background/aim: Although mirror therapy (MT) and phantom exercises (PE) have been shown to reduce pain, the efficacy of these
methods in terms of pain, quality of life (QoL), and psychological status (PS) has not been investigated and compared to date. The aim
of this study was to determine whether there is any difference between MT and PE in the treatment of phantom limb pain (PLP).
Materials and methods: Forty unilateral transtibial amputees (aged 18–45 years) participated in this study. The subjects were randomly
divided into ‘MT group’ and ‘PE group’. QoL was assessed using Short-Form 36 (SF-36), psychological status using the Beck depression
inventory (BDI), and pain intensity using a visual analog scale (VAS), before and at the end of the program, and on the 3rd and 6th
months thereafter.
Results: All assessments for all parameters improved significantly in both groups (P < 0.05). Comparison of the two groups revealed a
significant difference in changes for VAS and BDI in all measurements, and in pre- and posttreatment scores for all SF-36 parameters
(except for Role-Emotional) in favor of the MT group (P < 0.05).
Conclusion: While pain intensity decreased and QoL and PS improved in both the MT and PE groups, these improvements were greater
in the MT group.
Key words: Mirror therapy, phantom exercises, phantom limb pain, physiotherapy, rehabilitation

1. Introduction
Phantom limb pain (PLP) is a very frequent painful
sensation perceived within the absent part of the amputated
extremity. It is mostly reported in the distal part of the
phantom limb (1,2 ). PLP can be a distressing phenomenon
that becomes chronic and affects the patient’s quality of life
(QoL) (3,4).
The pathophysiology and the etiology of PLP have not
yet been fully established (5). Complex peripheral and
central mechanisms have been implicated (6). Flor (2)
reported reorganization in patients with PLP, expansion of
receptive fields affected by pain, and changes in the neuronal
activity from the adjacent zone into the deafferented zone,
representing the preamputation part of the extremity.
The incidence of PLP is 50%–80% after amputation (7).
Estimated prevalences of PLP of 78% (8), 59% (9, 10), 50%
(11), 29% (12), and 51% (13) have been reported. The high
incidence of PLP makes it important for beneficial and
cost-effective treatments to be found (14).
Many treatment options for PLP have been suggested.
The most commonly used methods in the treatment of

PLP include medication, surgical, and anesthetic methods,
cognitive-behavioral pain management, and physiological
approaches. Electromyography, thermal bio-feedback,
transcutaneous electrical nerve stimulation (TENS),
acupuncture, ultrasound, and immediate prosthetic
implementation have also been used in the treatment
of PLP as physiotherapeutic approaches (2). However,
there is a lack of high-quality clinical trials to support
the effectiveness of these treatments. The evidence level
of the effectiveness for these methods was found to be
low by several authors (15–18). Mirror therapy (MT) was
first used for PLP by Ramachandran (19). MT has been
described as the most promising method and as capable
of reducing PLP (20). During MT, the patient is asked to
place the amputated limb behind a mirror. The patient
then moves and watches the reflection of the intact limb in
the mirror. This creates a visual illusion of the movement
of the amputated side (21). In terms of the mechanisms
underlying MT, it has been suggested that the visual
illusion generates positive feedback to the motor cortex,
thus blocking the pain cycle (22). In addition, MT reverses
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the neural reorganization of the sensory–motor cortex
associated with PLP and thereby has been shown to be
effective in reduction of PLP (16, 23).
Ülger et al. (24) developed phantom exercises (PE)
based on MacIver’s (25) mental imagery exercises. The PE
technique consists of active movements of the sound limb
and imagined movements of the phantom extremity (24).
PE aims to modify and reverse cortical reorganization and
to restore the integrity of cortical information processing
using the patient’s own imagination perception.
The effectiveness of MT and PE has been investigated
in various studies. Promising results have been reported.
The present study was designed to evaluate and
compare the effects of MT and PE on the severity of
chronic PLP, and on QoL and psychological status in
lower-limb amputees (LLAs).
2. Materials and methods
2.1. Study design
The study was designed as a prospective randomized
clinical trial and was approved by the Hacettepe University
ethical committee, Ankara, Turkey (25.11.2010 / HEK
10 / 80 - 16). All participants gave informed consent to
participate.
2.2. Participants
Forty (23 male, 17 female; aged 18–45 years), posttraumatic,
unilateral transtibial amputees participated in this study.
All subjects were regularly attending the Prosthetics and
Biomechanics Unit of Hacettepe University. All patients
had PLP at the time of inclusion and experienced PLP
regularly (at least one episode per week), with an average
intensity of at least 40 on a visual analogue scale (VAS).
Amputees with systemic disease, mental or cognitive
impairment, any other neuropathic pain except for PLP,
stump pain, or using any walking aid or drug treatment
for PLP and with a history of surgery due to pain were
excluded. The patients did not take any medication for
pain relief during the study.
2.3. Procedures
Before beginning the study, the amputees were assigned
to one group using the closed envelop randomization
technique. There were 2 groups; each group consisted of
20 subjects. MT was administered to the ‘MT group’ and
PE to the ‘PE group’ all for 4 weeks. The exercises were
shown and patients practiced in the treatment unit for
one session with B.A.K. The subjects were then asked to
continue their exercises daily at home. They were checked
by phone call every other day and asked to attend the
treatment unit once a week during the first 4 weeks. Our
aim was to increase the motivation of patients and exercise
compliance. During the following weeks, the phone calls
and unit visits decreased to once a week and biweekly,
respectively.
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2.3.1. Mirror therapy
The patient placed the amputated limb inside a mirror box
so that it could not be seen. The reflective surface of a 120
× 40 cm rectangular mirror on the box was arranged to
face the intact limb. The mirrors were provided to patients
for MT applications, except for patients who wanted to
buy their own.
The subject was asked to perform synchronous and
periodic toe and ankle movements 10 times using both
the intact and phantom limbs for 15 minutes while
looking at the reflection of the intact limb in the mirror.
These movements were repeated for 1 session daily for 4
weeks. The exercises were described as ﬂexion/extension,
inversion/eversion of the foot, foot rotation around the
ankle, adduction with ﬂexion of the toes like clenching,
and abduction (spreading) with extension of the toes like
unclenching. The last exercise in 1 session was described
as relaxation of all muscles after strong contraction of all
foot and ankle muscles of both the phantom and intact
limbs (Figure 1) (4).
2.3.2. Phantom exercises
Exercises were performed with 15 repetitions. If the PLP
disappeared after fewer than 15 repetitions, exercise was
ended. The patients were asked to perform the PE daily
or in the case of recurrence of PLP in a day. They were
asked in which position they felt the phantom limb, and
instructed to keep that position, to place the intact limb
in the same position as their phantom limb, to move both
limbs in opposite directions, and to return them to the
starting position again. The patients were asked to repeat
these movements a couple of times. These movements
were: ankle ﬂexion/extension, inversion/eversion of the
foot, adduction with ﬂexion of the toes like clenching,
and abduction (spreading) with extension of the toes
like unclenching. After the patient felt relaxation in this
position, the movements were repeated as knee flexion/
extension and hip flexion/extension, respectively (to
proximal direction) until PLP disappeared (24).

Figure 1. Mirror therapy (view of the intact limb in the mirror).
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2.4. Measurements
All measurements were performed before (t0) and after
the procedures (t1), and were repeated at the 3rd (t2) and
6th (t3) months in the follow-up period in the treatment
department.
2.4.1. Clinical and demographic characteristics
At the initial evaluation, we recorded the patients’ clinical
and demographic characteristics.
The intensity of PLP was measured using VAS score, on
which patients could grade their pain along a 100-mm line
from “0” (no pain at all) to “100” (the most severe pain).
The participants marked the most severe degree of pain on
the VAS each day during the 4-week treatment period. The
patients were given a printed pain diary. In addition to the
pain diary, the intensity of PLP was measured at the t2 and
t3 controls (26).
QoL was evaluated using the Short-Form 36 (SF-36)
questionnaire. This consists of physical functioning (PF),
social functioning (SF), role limitation due to physical
problems (RP), role limitation due to emotional problems
(RE), mental health (MH), vitality (V), pain (P), and
general health perception (GH) domains. Possible scores
range between 0 and 100. Higher scores indicate better
health-related QoL (27). The validity and reliability of the
Turkish version was established by Kocyigit et al. (28).
The Beck depression inventory (BDI) was used to assess
psychological status. This contains 21 items, each scored
between 0 and 3. The total possible score is between 0 and
63, with higher scores indicating higher levels of depressive
mood (29). The reliability of this scale for Turkey was
determined by Hisli (30).
2.5. Statistical analysis
SPSS for Windows 21.0 and the “nparLD” and “nlme”
packages in R were used for statistical analysis. The
distribution of continuous variables was examined with
the Shapiro–Wilk test and normality plots. The normally
distributed continuous variables were expressed as mean
± standard deviation (mean ± SD), while the nonnormally
distributed variables and categorical variables were given
by median (range) and n (%), respectively. The continuous
demographic features of groups were compared with
independent samples t-test and Mann–Whitney U test with
respect to the distribution of the variable. The chi-square
test was used in the comparison of categorical features. The
related test statistics and P-values were presented.
The change of pain, quality of life, and depression
measurements across assessment time in groups were
compared by F1-LD-F1 design. ANOVA type statistics
and its P-value were given as a result. Friedman’s test was
used for comparison within the groups, and the Mann–
Whitney U test was used for analysis between the groups
for the aforementioned measurements. Bonferronicorrected P-values were given.

The pain intensity levels of the groups, recorded over
28 days, were analyzed with linear mixed models to detect
the any difference. The covariance structure of random
effects was set unstructured, as the autocorrelational
residuals covariance pattern was determined with respect
to the minimum information criteria such as AIC and BIC.
AIC, regression coefficient, and their standard errors (SE)
were given. P < 0.05 was regarded as indicative of statistical
significance.
3. Results
The participants’ demographic and clinical characteristics
are presented in Table 1. There were no significant
differences in terms of demographic or clinical parameters
between the two groups at baseline (P > 0.05).
Most of the patients had experienced telescoping as
they reported that they felt PLP at the distal part of the
phantom limb, especially around the fingers, the heel, and
the ankle. PLP appeared immediately after amputation
in all of the subjects in our study. Most of the patients
reported that they felt PLP when they became tired and
after standing for a long time. A few subjects reported that
the pain was increased due to prolonged immobility of the
stump. Pain was decreased when they moved or lightly
rubbed their stumps. Our patients generally described
PLP as burning, throbbing, cramping, cutting, stabbing,
sharp, and shooting sensations.
The change in VAS, QoL scores except role limitation
due to physical/emotional problems, and BDI were
different between the groups (P-value of ANOVA-type
statistics (ATS) <0.001, Table 2).
No signiﬁcant differences between the groups were
observed at baseline in terms of VAS, SF-36, or BDI scores
(P > 0.05). The groups were homogeneous in terms of these
assessment variables. There was a significant reduction
in VAS and BDI scores and a significant improvement in
SF-36 PF, SF, MH, and V subscale scores in favor of the
MT group at t1, t2, and t3 assessment controls (P < 0.05).
Differences between the two groups were observed for the
SF-36 RE subscale score at t2, t3 assessments (P = 0.035)
and for the SF-36 P and GH subscale sore at t1 assessment
(P = 0.001 and P = 0.020, respectively) (Table 2).
The changes in pain intensity as measured by VAS over
a period of 28 days according to the patients themselves
are shown in Figure 2. There was no difference between
the groups with respect to the baseline pain intensity (P
= 0.804, Table 3). Although the pain intensity decreased
in both groups over 28 days, the amount of decrease was
0.501 (SE: 0.175) units more in the MT group for each time
point than the PT group (P = 0.004, Table 3).
4. Discussion
Although MT and PE have both been shown to reduce
pain, the efficacy of these treatment methods in terms of
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Table 1. Demographic and clinical characteristics of the study population.
MT group
(n = 20)

PE group
(n = 20)

Mean ± SD / Median(range)

t/Z

P- value

Age (years)

32.60 ± 7.39

29.60 ± 6.87

1.329

0.192

Height (cm)

167.70 ± 6.84

170.05 ± 6.17

1.141

0.261

Weight (kg)

67.13 ± 9.74

68.13 ± 11.64

0.295

0.770

BMI (kg/m²)

23.84 ± 2.57

23.24 ± 3.63

0.608

0.547

Months since amputation

13(3–51)

13.5(3-53)

0.176

0.862

Stump length (bone end) (cm)

20.96 ± 5.58

20.78 ± 5.44

0.100

0.921

Stump length (soft tissue end) (cm)

24.49 ± 5.64

23.86 ± 5.50

0.358

0.723

χ²

P- value

0.000

1.000

0.401

0.527

1.168

0.761

–

–

0.000

1.000

n(%)
Sex
Male

12(60)

13(65)

Female

8(40)

7(35)

Right

12(60)

9(50)

Left

8(40)

11(50)

Amputated side

Educational status
Primary

6(30)

4(20)

Secondary

3(15)

5(25)

High

8(40)

9(45)

University

3(15)

2(10)

Employment status
Unemployed

5(25)

7(35)

White collar

7(35)

5(25)

Manual worker

4(20)

4(20)

Retired

1(5)

1(5)

Tradesman

3(15)

3(15)

Marital status
Married

12(60)

12(60)

Single

8(40)

8(40)

MT group: mirror therapy group, PE Group II: Phantom exercise group, SD: standard deviation.
P < 0.05 was considered significant based on t: independent sample t-test, z: Mann–Whitney U Test, and χ²: chi-square test
BMI: body mass index

QoL and PS have not been investigated and compared to
date. MT, which has become increasingly popular in the
last 20 years, was first tested in an amputee with PLP by
Ramachandran (31). Although MT has been shown to
reduce pain and improve motor functions in PLP patients,
most studies consist of uncontrolled trials or case series.
There are only 5 randomized controlled studies with
small sample sizes, using heterogeneous methods without
comparisons of the protocols (32). We aimed to determine
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whether there is any difference between MT and PE in
the treatment of PLP by the present study. This study has
showed that both treatments reduced PLP and improved
QoL and psychological status in LLAs. The difference in
terms of the efficacy of the two treatment methods was in
favor of the MT group.
In the two case studies, the subjects’ PLP resolved
completely in a couple of weeks (4,33). Ramachandran et
al. (34) applied MT to an upper-extremity amputee with
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Table 2. Changes in means values for pain perception, health-related quality of life and psychological status
within groups and comparison of these variables between the groups.
Measurement /

MT group
(n = 20)

PE group
(n = 20)

assessment

Median (range)

Median (range)

Z

Adj. P

t0

70.5 (45–91)1,2

67.5 (42–85)1,2

0.528

1.000

t1

7.5 (0–18)

22.0 (13–27)

5.258

<0.001

t2

2.0 (0–10)1

12.0 (7–18)1

5.309

<0.001

t3

0.0 (0–5)

6.5 (0–11)

5.215

<0.001

χ2; Adj.p

55.918; < 0.001

ATS; p

44.327; <0.001

PLP (VAS) (mm)
3

3

2,3

2,3

60.000; < 0.001

SF-36- Physical functioning
t0

34.1 (25.7–52.9)1,2,3

37.3 (25.7–52.9)1,2

0.400

1.000

t1

49.9 (44.6–57.1)

1

39.4 (36.2–52.9)3,4

3.342

0.003

t2

57.1 (48.8–57.1)

2

1,3

49.9 (40.4–57.1)

3.169

0.006

t3

56.1 (44.6–57.1)3

48.8 (36.2–57.1)2,4

2.796

0.021

χ ; Adj.p

53.182; <0.001

52.689; <0.001

ATS; p

14.333; <0.001

2

SF-36- role limitation due to physical problems
t0

42.1 (28.0–56.2)1,2

42.1 (28.0–56.2)1,2

0.354

1.000

t1

52.7 (42.1–56.2)

42.1 (35.0–56.2)

1.839

0.264

t2

56.2 (49.2–56.2)1

56.2 (42.1–56.2)1,3

1.606

0.433

t3

56.2 (42.1–56.2)

52.7 (42.1–56.2)

1.883

0.239

χ2; Adj. P

38.147; <0.001

ATS; P

2.552; 0.086

2

3

2

36.069;<0.001

SF-36- pain
t0

33.2 (19.9–51.6)1,2,3

33.4 (19.9–51.6)1,2

0.208

1.000

t1

49.1 (46.5–55.9)1

42.2 (37.5–51.6)3,4

3.676

0.001

t2

55.9 (51.6–55.9)

1,3

49.1 (37.5–62.7)

2.355

0.074

t3

55.9 (51.6–55.9)3

49.1 (37.5–62.7)2,4

2.246

0.099

χ ; Adj. P

53.827; <0.001

52.185; <0.001

ATS; P

8.997; 0.001

2

2

SF-36- general health
t0

28.9 (19.5–50.9)1,2,3

28.9 (19.5–50.9)1,2

0.083

1.000

t1

49.7 (39.2–59.3)

1

40.3 (34.5–50.9)

2.813

0.020

t2

59.3 (45.3–59.3)

2

1,3

50.9 (39.2–59.3)

1.766

0.310

t3

59.3 (45.3–59.3)3

50.9 (39.2–59.3)2,4

1.747

0.323

χ ; Adj. P

54.134; <0.001

57.659; <0.001

ATS; P

5.834; 0.008

2

3,4

SF-36-vitality
t0

34.9 (27.8–46.7)1,2,3

34.9 (27.8–46.7)1,2

0.208

1.000

t1

53.8 (53.8–56.2)

3,4

46.7 (39.6–53.8)

5.389

<0.001

t2

63.3 (53.8–65.6)2

55.0 (49.1–63.3)1,3

3.212

0.005

t3

63.3 (53.8–65.6)

53.8 (49.1–63.3)

3.310

0.004

1

3

2,4
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Table 2. (Continued).
χ2; Adj. P

54.134; < 0.001

ATS; P

14.970; < 0.001

58.119; < 0.001

SF-36-social functioning
t0

35.4 (24.6–46.3)1,2,3

35.4 (24.6–46.3)1,2

0.187

1.000

t1

46.3 (40.9–51.7)1

38.2 (35.4–46.3)3,4

3.120

0.007

t2

51.7 (46.3–57.1)

2

49.0 (40.9–57.1)

2.953

0.013

t3

51.7 (46.3–57.1)

3

49.0 (40.9–57.1)

2.767

0.023

χ2; Adj. P

54.000; < 0.001

ATS; P

6.984; 0.007

1,3
2,4

57.675; <0.001

SF-36- role limitation due to emotional problems
t0

44.8 (23.7–55.3)1,2

44.8 (23.7–55.3)1,2

0.241

1.000

t1

55.3 (44.8–55.3)

44.8 (34.3–55.3)

1.396

0.651

t2

55.3 (55.3–55.3)1

55.3 (44.8–55.3)1

2.623

0.035

t3

55.3 (55.3–55.3)2

55.3 (44.8–55.3)2

2.623

0.035

χ ; Adj. P

38.257; < 0.001

39.000; < 0.001

ATS; P-value

2.316; 0.104

2

SF-36- mental health
t0

27.7 (20.9–41.4)1,2,3

27.7 (20.9–41.4)1,2

0.028

1.000

t1

44.8 (36.8–48.2)

1

33.4 (32.3–45.9)

4.178

<0.001

t2

48.2 (39.1–59.5)

2

39.1 (34.5–52.9)

3.031

0.010

t3

48.2 (39.1–59.5)3

39.1 (34.5–52.7)2

3.223

0.005

χ ; Adj. P

53.848; < 0.001

55.561; < 0.001

ATS; P-value

11.145; <0.001

2

3
1,3

BDI
t0

20.5 (12–44)1,2

19.5 (12–41)1,2

0.163

1.000

t1

9.0 (6–32)

3,4

15.0 (9–32)

2.984

0.011

t2

5.0 (0–24)1,3

13.0 (5–29)1,3

3.689

0.001

t3

5.0 (0–22)

13.0 (5–27)

4.360

<0.001

χ2; Adj. P

56.347; < 0.001

ATS; P-value

18.101; <0.001

3,4

2,4

2,4

56.105; < 0.001

MT group: mirror therapy group. PE group II: phantom exercise group
*Adj.: adjusted P < 0.05 was considered significant based on z: Mann–Whitney U test, χ2: Freidman’s Test, ATS:
ANOVA-type statistics of nonparametric LD designs
PLP: Phantom limb pain
VAS: visual analog scale
SF-36: Short Form-36
BDI: Beck depression inventory
t0: assessment before treatment, t1: assessment at the end of the treatment, t2: assessment 3 months after
treatment, t3: 6 months after treatment

the use of magnifying and minifying lenses for 2 sessions.
PLP intensity decreased from 8 to 0 on VAS with the use
of minifying lenses.
In randomized controlled trials, PLP intensity of the
patients in the MT group decreased significantly more
than in the control group (21, 35-37). In accordance with
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previous studies, the pain intensity decreased dramatically
from 70.7/100 to 7.5/100 in MT group and from 67.5/100
to 22/100 in PE group on VAS at the end of the treatment
period during our study. The patients in the MT group
reported significant reduction in pain intensity compared
with the PE group.
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Figure 2. Pain intensity during the 28-day treatment period.

Table 3. Results of linear mixed modeling for pain intensity over
28 days.
Coefficients

β

SE (β)

P

Intercept

61.997

3.018

<0.001

Time (MT vs PT)

−1.610

0.124

<0.001

Group

−1.065

4.269

0.804

Time*Group

−0.501

0.175

0.004

AIC:6333.052

In Ülger’s (24) study, 20 amputees were randomly
allocated into one of the two groups. The reduction in PLP
in the PE group was significant after 4 weeks. There have
been only two studies in the literature using PE. Brunelli
et al. (38) used modified phantom exercises combined
with progressive muscle relaxation and mental imagery
exercises twice a week for 4 weeks. A significant decrease
in intensity of PLP was found in the treatment group
compared with the control group.
In our study, pain intensity decreased in both groups,
but the decrease level was higher in the MT group. We
attributed this to the effect of visual stimuli on patients
while performing exercises during MT. The results of our
study are in line with those of various previous studies.
However, while studies in the literature have reported
positive results, most were uncontrolled trials or case
studies of low methodological quality. Those results
regarding the effectiveness of MT and PE in PLP are
therefore far from conclusive. From that perspective,
our results may provide guidance for future studies. The
participants in our study reported that PE, and especially
MT had a positive and rapid impact on reducing pain
compared with treatment methods previously used for
PLP. They reported that pain decreased from the first
sessions of MT and expressed satisfaction with this novel

sensory experience.
In one study, SF-36 scores were significantly lower
in amputees compared to healthy individuals (39).
Another study determined significant differences
between individuals with or without PLP in terms of
SF-36 subscores (27). In contrast, McCartney et al. (40)
reported that PLP had a moderate to significant effect on
QoL, but only in a small percentage of patients. Houston
and Dickerson (41) evaluated QoL in a study using MT to
treat PLP in 14 vascular LLAs for 4 weeks and observed
a significant improvement in QoL. Very few studies have
investigated the relationship between the treatment of PLP
and QoL. According to our study results, QoL improved
in both groups, although the level of improvement was
significantly higher in the MT group. Our results are
similar to those of the limited number of studies in the
literature. However, this is the first randomized controlled
trial investigating QoL of patients with PLP receiving MT
and PE.
One of the most important reported predictors of QoL
in amputee patients is depression (42). A correlation has
been shown between high depression scores, increased
pain intensity and low QoL. In our study, patients were
initially determined to have a moderate level of depression.
This is in agreement with the present data. Darnall and Li
(14) tested the effectiveness of self-delivered home-based
MT in treating PLP. Although they observed a tendency
towards depression in their subjects, they determined no
correlation between the level of depressive symptoms and
treatment response.
General psychological conditions in both groups in
our study were positively affected compared to baseline.
However, a significant difference between the two groups
in favor of the MT group was observed at all t1, t2, and
t3 assessments. Few studies have examined changes in
psychological status as a result of PLP treatment. Only
one study assessed the psychological status of individuals
undergoing MT (14). No previous studies have examined
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the effect of PE on psychological status or compared
the effects of the two therapeutic approaches with
other treatment methods. Ours is the first randomized
controlled study to examine and compare the effects of MT
and PE on the psychological status of amputees with PLP
and to have achieved positive results. Therefore, while our
patients’ pretreatment psychological status was consistent
with those in the literature, there are no previous studies
against which we can compare our treatment results.
The time since amputation was less than 2 years for
some of our participants. The intensity of PLP can reduce
spontaneously by the time the subject is in subacute phase.
This situation should be considered as a limitation that
could have affected our study results. The small sample
size and the absence of the information about wash-out
time for the medications were other limitations of our
study. The subjects did not use any medication for pain
during the study. However, we did not assess the wash-out
time for the medications prior to the study.

The number and duration of sessions of MT was higher
than the frequency of application of PE. Although the
methods of application of MT and PE are different, their
mechanisms of action are similar. Therefore, we assume that
the difference of effectiveness between the two therapies
could be due to a difference in frequency.
In conclusion, the treatment procedures in this study
reduced PLP and improved QoL and psychological status
in the short term. The results were also better in the MT
group than in the PE group. Our results demonstrate the
applicability of both MT and PE in the treatment of PLP
and bring a different perspective to that treatment. We think
that both MT and PE may be useful guides for future studies
since they are easy to implement, cost-effective, and efficient.
The use of MT or PE should now be compared with
various treatment methods in studies involving larger
numbers of amputees and different amputation levels.
Further studies are now also needed to reveal the long-term
effects of MT and PE.
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